We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AusPAR: Infliximab (rmc)
Australian Public Assessment Report
Device/Product Name
Remsima, Emisima, Flixceli, Inflectra
Active ingredients
Infliximab (rmc)
AusPAR Date
Published
Sponsor
Submission Number
PM-2013-03247-1-3
Submission Type
An application to register a biosimilar
Decision
Approved